课题基金 / 基金详情

Malaria Transporters as a novel target for Antimalarial Campaign

Malaria Transporters as a novel target for Antimalarial Campaign
疟疾转运蛋白作为抗疟运动的新目标
批准号:
9205623
负责人:
Ajit Jadhav
金额:
$1.9万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Ajit Jadhav的其他基金

相似基金

相关文献

中文摘要
翻译
项目要点:使用8种不同介质的微型至1536孔板格式,筛选MMV box、NPC和NCGC MIPE文库的集合。阳性化合物正在进行测试,以进行进一步的化合物选择。 在此期间,NCGC与NIH和校外调查人员进行了180多次积极的合作,促进了整个人类疾病范围内的药物发现工作。这些努力已经产生了100多个高通量筛选和近60个药物化学活动,为我们的合作者和一般研究社区提供了丰富的出版物和前景光明的小分子线索。此外,NCGC还承担了一些信息学挑战,以更好地利用现有的药物和疾病目标信息,并为公众提供易于获取的资源,进一步催化人类疾病新疗法的开发。
英文摘要
Project highlights: using miniaturized to 1536-well plate format with 8 different media, collections of MMV box, NPC and NCGC MIPE libraries were screened. The positive compounds are being tested for further compound selections. During this period, the NCGC has fostered and maintained over 180 active collaborations with both NIH and extramural investigators, facilitating drug discovery efforts across the entire spectrum of human disease. These efforts have led to over 100 high-throughput screens and nearly 60 medicinal chemistry campaigns, providing our collaborators and the general research community a wealth of publications and promising small molecule leads. In addition, the NCGC has undertaken a number of informatic challenges to make better use of existing drug and disease target information and provide the general public with easily accessible resources, further catalyzing the development of new therapies for human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Irreversible targeting of mammalian thioredoxin reductase 1 (TrxR1) for anticancer therapy
Phenotypic Screening to Identify Regulators of CFTR Localization
Selective inhibitors of citron rho kinase (CIT-K)
A quantitative qRT-PCR screen for activators of TRIB1 expression
国内基金
海外基金
棉铃虫葡萄糖转运蛋白(Glucose transporters)的分子鉴定
  • 批准号:
    31601644
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    袁一杨
  • 依托单位: